Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-smal...
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer
About this item
Full title
Author / Creator
Miyawaki, Taichi , Naito, Tateaki , Yabe, Michitoshi , Kodama, Hiroaki , Nishioka, Naoya , Miyawaki, Eriko , Mamesaya, Nobuaki , Kobayashi, Haruki , Omori, Shota , Wakuda, Kazushige , Ono, Akira , Kenmotsu, Hirotsugu , Murakami, Haruyasu , Mori, Keita , Harada, Hideyuki , Takahashi, Kazuhisa and Takahashi, Toshiaki
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors plus chemotherapy have become the standard first line of treatment in patients with advanced non-small-cell lung cancer (NSCLC). However, few studies have explicitly focused on the impact of weight loss on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy....
Alternative Titles
Full title
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2575374446
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2575374446
Other Identifiers
ISSN
0941-4355
E-ISSN
1433-7339
DOI
10.1007/s00520-021-06572-4
